Epilepsy & Seizures
Epileptic lesions due to malformation of cortical development
Sep. 06, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
DiGeorge and velocardiofacial syndrome (22q11.2 deletion syndrome) is the most common microdeletion disorder in humans and, hence, one of the most common multiple malformation syndromes, with an estimated prevalence of 1 in 2000 to 1 in 4000 (35). It is characterized by craniofacial anomalies, conotruncal heart disease, thymic aplasia and hypoplasia, hypocalcemia, and psychiatric illness. In this article, the author reviews the history, clinical features, and genetic basis of this common disorder.
• DiGeorge and velocardiofacial syndrome (22q11.2 deletion syndrome) is the most common microdeletion disorder in humans and, hence, one of the most common multiple malformation syndromes, with an estimated prevalence of 1 in 2000 to 4000. | |
• It is characterized by craniofacial anomalies, conotruncal heart disease, thymic aplasia or hypoplasia, hypocalcemia, and psychiatric illness. |
In 1968, DiGeorge described congenital absence of the thymus and parathyroid glands in four infants with recurrent infections and hypocalcemia (43). In 1979, Conley and co-workers broadened the phenotype of DiGeorge syndrome to include conotruncal (outflow tract) defects of the heart as well as characteristic facial features, including a bulbous nose, dysplastic ears, and micrognathia (33).
Strong reported a familial syndrome of the right-sided aortic arch, facial dysmorphism, and cognitive and psychiatric dysfunction in 1968 (176). Ten years later, Shprintzen and colleagues profiled a series of 12 patients with a combination of cleft palate, congenital heart disease, unique facial features (long face with malar flattening, small palpebral fissures, long nose with bulbous tip, dysplastic ears, and micrognathia), learning disabilities, and short stature and called the condition velocardiofacial syndrome (165). Conotruncal anomaly face syndrome, originally described in the Japanese literature (98), comprises clinical features of both DiGeorge syndrome and velocardiofacial syndrome.
The initial evidence for involvement of genes on chromosome 22 in the etiology of DiGeorge syndrome included a family with a chromosome 2;22 translocation. Family members with an unbalanced rearrangement that resulted in monosomy 22q11.2 had clinical features of DiGeorge syndrome (38). Subsequently, cytogenetically visible interstitial deletions of 22q11 were detected in approximately 25% of patients with DiGeorge syndrome (158). Southern blotting and DNA dosage analysis revealed microdeletions within 22q11 in DiGeorge syndrome patients (56). The finding of several patients with velocardiofacial syndrome and a deletion 22q11.2 using fluorescence in-situ hybridization suggested that DiGeorge syndrome and velocardiofacial syndrome were related disorders (159). It is evident that the overlapping features of DiGeorge syndrome and velocardiofacial syndrome presumably result from haploinsufficiency for the same genes (95).
With the advent of molecular genetics, DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face syndrome were found to have a similar 22q11.2 microdeletion as the basis for their overlapping clinical features (158; 159; 24). This 22q11.2 deletion syndrome is now recognized as one of the most common multiple malformation syndromes. The acronym “CATCH22” (cardiac defects, abnormal facies, thymic hypoplasia, cleft palate, and hypocalcemia) was conceived; however, because this term may be construed as insensitive, it is not universally accepted (212; 217). The compound term “DiGeorge and velocardiofacial syndrome” calls attention to the phenotypic spectrum using historically familiar names (106) and is especially applicable when phenotypic features manifest in the absence of the chromosomal deletion (126).
Broad inter- and intrafamilial variability exists in the clinical spectrum of DiGeorge and velocardiofacial syndrome (81). The phenotype has expanded considerably within the last several years and includes over 150 associated findings. The following are the major clinical manifestations:
Audiologic findings. Hearing impairment (conductive, sensorineural, or mixed hearing loss) is present in 40% to 60% of patients and seems to be due to cochlear damage (45; 125; 195).
Cardiovascular findings. Congenital heart disease (conotruncal defects) is present in approximately 68% of individuals to 85% of individuals with DiGeorge and velocardiofacial syndrome (221; 106). Indeed, the presence of conotruncal defects, especially coupled with psychiatric disorders, is a compelling reason to pursue cytogenetic analysis, even in adults (202). The most common anomalies include ventricular septal defect, tetralogy of Fallot, and aortic arch anomalies--for example, interrupted aortic arch and right-sided aortic arch (221; 115; 154; 143). Anomalies of the internal carotid arteries are also reported (64). Non-compaction of the left ventricular myocardium has been reported in this condition (145; 44), but the association is not understood and could be coincidental (172). Vascular anomalies may be encountered in the cervical region (eg, medial deviation of the internal carotid artery) (175).
Craniofacial findings. Microcephaly is present in approximately 40% of individuals (64), and craniosynostosis has been recognized in a small subset of patients (02). Characteristic facial features include a long face with malar flattening, short palpebral fissures, small dysplastic ears, prominent nose with broad nasal root, bulbous tip, and deficiency of the nasal alae, and micrognathia. Dental anomalies include enamel hypoplasia, hypodontia, aberrant tooth shape, and delayed tooth eruption (99). The occurrence of cleft palate ranges from 33% (115) to 98% (64). Discrepancies between reported series probably reflect ascertainment bias with higher frequencies of cleft palate in those series originating from craniofacial clinics. The majority of affected individuals, with or without overt cleft palate, typically have hypernasal speech (the result of velopharyngeal insufficiency) complicated by upper airway asymmetry, platybasia, muscle hypotonia, adenoid hypoplasia, and other neuroanatomical abnormalities (211). Velopharyngeal insufficiency may also predispose to otitis media and conductive hearing loss. Hearing loss may also be associated with malformations of the middle or inner ear, identifiable by CT or MR imaging (197). Velopharyngeal insufficiency and compromised nasal airway patency may impact olfaction as well (169). Others have also noted abnormalities in olfaction, which are not related to age or sex (129). Anterior glottic webs are found in a minority of individuals with DiGeorge and velocardiofacial syndrome (128). Speech delay, coupled with learning disability, hearing loss, and dysmorphic facies, is suggestive of the condition and indicates further workup (199).
Endocrinologic findings. Hypocalcemia is seen in 20% to 63% of patients, typically presenting between birth and 3 months of age (64; 115; 106). Approximately 10% of these infants present with hypocalcemic-related seizures (212), and Chvostek and Trousseau signs may not be present. Most patients have resolution of hypocalcemia by 1 year of age; however, recurrence of hypocalcemia in later childhood or adulthood, secondary to transient congenital hypoparathyroidism, is reported (74; 181). Hypothyroidism, autoimmune hyperthyroidism, and growth hormone deficiency may be seen in these individuals (64; 210; 161; 189). In fact, thyroid disease (hyper- or hypothyroidism) has been diagnosed in nearly 10% of patients in one study (166). Hypercalcemia in early childhood has been reported in a patient with a de novo mutation in AP2S1 (186).
Genitourinary findings. Renal anomalies are present in up to 40% of individuals and include absent, dysplastic, or multicystic kidneys, obstructive abnormalities, duplicated kidney and collecting system, and vesicoureteral reflux (42; 154; 193). Utero-vaginal aplasia (Mayer-Rokitansky-Kuster-Hauser syndrome) has been reported in a few patients (131). Cryptorchidism, hypospadias, and imperforate anus are occasionally present (64; 154; 216).
Gastrointestinal findings. Feeding difficulties are present in approximately one-third of infants, often necessitating gastrostomy tube or nasogastric tube placement (125). Esophageal abnormalities, Hirschsprung disease, and anteriorly placed anus are less common (51).
Immunologic findings. Defects in T-cell production and function (secondary to thymic aplasia or hypoplasia) are present in 25% to 75% of patients (154; 177). Infections, thus, pose a substantially increased risk over the general population and may be life-threatening. Secondary humoral deficiencies can also occur, resulting in a form of variable combined immunodeficiency (187). Some patients with severe combined immunodeficiency (SCID) are subsequently found to have 22q11 deletion syndrome (15). In addition, autoimmunity is not uncommon (61). Vitamin D supplementation may help prevent the development of autoimmune or proinflammatory disease (109). Juvenile rheumatoid arthritis-like polyarthritis is reported in individuals with DiGeorge and velocardiofacial syndrome (178). Idiopathic thrombocytopenic purpura is described in some individuals (112).
Musculoskeletal findings. Short stature is present in approximately one-third of individuals (64). Cervical spine abnormalities (eg, open or cleft vertebral arch, platybasia, fused vertebrae) are relatively common, and so precautions should be taken during medical treatments and even during the pursuit of ordinary life functions (80; 175). In one review, vertebral arch anomalies were recognized in some 60% of patients but were not associated with spinal cord encroachment or impingement (100). Other anomalies of the skeletal system include Sprengel anomaly, scoliosis, and limb abnormalities, most commonly talipes equinovarus, polydactyly, and syndactyly (154; 152). Of these, scoliosis has been observed in nearly one half of patients (82). Approximately 60% of individuals have long, slender fingers (64). Inguinal and umbilical hernias are also common.
Neurologic findings. Seizures were reported in approximately 21% of individuals in one large series (154). The majority of seizures are associated with hypocalcemia, although febrile seizures and true epilepsy must also be considered (49). In the latter instance, cognitive development, psychology, and motor impairment are recognized associations. In adult patients, the prevalence of epilepsy and acute symptomatic seizures is more likely due to exposure to antipsychotic and antidepressant medication (213). One case of both hypocalcemia-induced seizure and epilepsy associated with spina bifida has been reported (97). Hypotonia in infancy and early childhood is present in most patients, resulting in delayed motor milestones. Movement disorders may occur secondary to endocrine diseases or musculoskeletal anomalies; patients may also be susceptible to early-onset Parkinson disease (21; 136; 147). Motor signs include bradykinesia, rigidity, and rest tremors, which together are apparent in almost one-half of patients (22). These signs tend to increase with age and are likely caused by a number of factors, one of which may be calcification of the basal ganglia, itself an effect of the calcium derangements common to the syndrome (22). In one study, the mean age of onset of Parkinson disease in patients with 22q11.2 deletion syndrome was 39 to 40 years; diagnosis tended to be delayed if patients carried a previous diagnosis of psychosis, seizure disorder, or mood disorder or anxiety (20). In a study of younger patients (median age 12.7 years), dystonia occurred in isolated fashion or with upper limb involvement (36). Asymmetrical facies and facial nerve palsies are described (154). Cognitive impairment is common, with mean verbal IQ scores in the borderline range of mental deficiency in both preschool and school-aged children (65). More severe deficits are noted in receptive language than expressive language (62). Verbal IQ scores are generally higher than performance IQ scores (179), consistent with a nonverbal learning disability. A specific cognitive profile with impairments in visuospatial, arithmetical, and executive tasks is noted (222). Problems in social-emotional functioning and attention and concentration are common.
Ocular findings. Blood-vessel anomalies (such as tortuous retinal vessels), colobomas, posterior embryotoxon, and strabismus may be associated with DiGeorge and velocardiofacial syndrome (64; 125). Additional findings include abnormalities of the orbits, eyelids, or eyes (hooding, narrow palpebral fissures, narrow or widened interorbital space, sparse and thin eyebrows and eyelashes, blepharitis, distichiasis), posterior embryotoxon, and tortuous retinal vessels; refractive errors, iris remnants, and strabismus are recognized as well (63).
Psychiatric findings. Individuals with DiGeorge and velocardiofacial syndrome are at risk of developing a range of psychiatric illnesses, most often appearing late in adolescence or early adulthood (64; 151; 91; 83). This risk has been estimated at 25 times that of the general population (164). These conditions frequently include pronounced separation anxiety and night terrors in childhood and attention deficit hyperactivity disorder, wide mood swings, and obsessive-compulsive disorder in adolescence. Altered development of early auditory processing is a marker for the later appearance of schizophrenia (26). Preadolescent and young adolescent children studied longitudinally show slowed growth in attention regulation and subclinical symptoms of schizophrenia; lower academic achievement and neurocognition, with increased social and behavioral difficulties, are reported (83). Social cognitive training has proven effective in a small group of adolescents (162). Some suggest that the predominantly affective symptoms seen in early childhood and adolescence may evolve into schizophrenia or schizoaffective disorder in adulthood (132). The deletion carries the third highest recognized risk for schizophrenia, which may develop in 20% to 25% of patients (150; 144; 31). In addition to the presence of the deletion, a wide range of polygenic and other factors may elevate the risk of developing psychosis. These include neuropsychological deficits, symptoms of depression, premature birth, and bullying (191; 124; 148). The diagnosis of Parkinson disease may be overlooked if signs are interpreted as a side effect of antipsychotic medication (223).
Catatonia is recognized, especially in patients with psychiatric symptoms that are refractory to treatment (55; 25). Interictal schizophrenia-like psychosis has been reported in an adult who had experienced childhood-onset epilepsy (184). In addition, reports describe a spectrum of bipolar disorders, including bipolar I, bipolar II (ultracyclers), cyclothymic, and schizoaffective (manic) disorders in these individuals with onset in late childhood or early adolescence (mean age of onset is 12 years) (141). Chronic mania has been reported (149), but it is not clear if behavior remains stable during the patient’s lifetime (06). Autism spectrum disorders are present in about 18% to 50% of children with 22q11.2 deletion syndrome (204; 140). The severity of behavioral and psychiatric disorders is such that a majority of caregivers believe they are the most challenging aspect of this disorder (90).
Prognosis in the neonatal period usually depends on the severity of the cardiac malformation, if present, and immune function. Cardiac surgery may be complicated by depressed immune status, neonatal hypocalcemia, pulmonary vascular reactivity and increased airway bleeding, and a number of structural airway anomalies, including tracheomalacia, bronchomalacia, bronchospasm, and malpositioned bronchus. Cardiac transplantation has been employed in patients with severe cardiac anomalies. In one series, median age at transplant was 5 years; median survival posttransplant was 5.4 years, with no differences observed in the incidence of rejection, infection, or survival between patients with or without the deletion (215). Malformations of the larynx may include laryngeal (glottic) web or cleft, subglottic stenosis, laryngeal paralysis, vocal nodule, and laryngomalacia (28; 111), and they may require surgery in the majority of cases (88). Not surprisingly, hospital stays in general are longer and require more resources (134). Most individuals will have some degree of developmental delay and learning disabilities (64); however, a great degree of variability exists between and within families (115; 106). Obesity with hyperphagia in a small subset of patients may have a psychiatric basis (16). Intellectual development can be moderately, severely, or profoundly affected (53). Children are challenged by cognitive, social, and emotional issues, but these can be counterbalanced by strengths such as kindness, humor, persistence, and enthusiasm; in quality-of-life testing, boys score significantly lower than girls (116). These attributes may stem from the observation that patients’ verbal skills outweigh performance IQ and visuospatial memory (59). Such deficits in spatial and temporal processing, whereby individuals cannot remember the positions of objects, are complex and influence the performance of patients’ working- or short-term memory (214; 11). Disruption in the neural circuitry critical to working memory may be suggestive of a psychotic disorder (130). Patients have difficulty focusing, planning, and executing specific acts (59). Depressive, defiant, and anxiety disorders may be predictive of later psychosis (07). Psychosis has also been correlated with progressive intellectual decline (54). Approximately 10% to 30% of individuals will develop psychiatric illness ranging from mild depression to frank psychosis (64; 151). In one study, diffusion tensor MRI identified white matter abnormalities, with apparent lower axonal integrity, in these patients (13). In another study, the technique demonstrated disruption of axonal coherence in the right inferior fronto-occipital fasciculus—a finding thought to have prognostic implications for cognition and psychosis (137).
Cognitive and behavioral issues play a very significant role in determining quality of life (118). The precise nature of the cytogenetic abnormality may also have a bearing on prognosis. One woman with apparent “genetic dosage compensation,” ie, deletion of one copy of 22q11.2 and reciprocal duplication of the other copy, was phenotypically normal (03). Early-onset Parkinson disease is an indication for genetic workup (147).
In one large study (n=434), the risk for substance abuse in later life was reduced for patients with the deletion (201). Adults are at risk for sudden death. Mechanisms are probably multiple and may include fatal arrhythmia. Again, mechanisms are unclear; in a study of five patients, for example, sympathetic activity was normal (198). Life expectancy is reduced for patients compared to unaffected family members. In a study of 309 patients, the median age at death was 46.4 years (192). The presence of congenital heart disease plays an important role in the course; the probability of surviving to age 45 is 72% for those with heart defects and 95% for those without.
A 15-year-old boy with mild mental retardation and unusual facial features began to experience behavioral changes, which were first interpreted as isolation and depression. He soon developed auditory and visual hallucinations as well as delusions. His past medical history is significant for "failure to thrive" during infancy due to difficulty breastfeeding and recurrent nasal regurgitation. Developmental milestones were delayed; he began to walk at 17 months and first spoke single words around 18 months of age. He had recurrent otitis media with persistent conductive hearing loss and had tympanostomy tubes placed at 18 months of age. An inguinal hernia was repaired at 4 years of age. A neurodevelopmental evaluation at 9 years of age noted hypernasal speech and estimated cognitive abilities in the borderline to mild range of mental deficiency.
He was hospitalized and evaluated by psychiatry and neurology services. He was noted to have unique facial features, which included a relatively long face with malar flattening, long nose with a bulbous nasal tip, short palpebral fissures, small ears with thickened helices, long slender fingers, flat affect, tremor, and a slow, awkward gait. Repeat neuropsychological testing revealed a 30-point decline in his full-scale IQ. EEG and head CT scan were normal. A fluorescence in situ hybridization test for DiGeorge and velocardiofacial syndrome showed a 22q11.2 deletion. Echocardiogram and renal ultrasound were normal. Parental fluorescence in-situ hybridization studies were normal.
Approximately 76% of individuals to 90% of individuals with DiGeorge and velocardiofacial syndrome have a chromosome 22q11.2 microdeletion recognizable by fluorescence in-situ hybridization (46; 115). Approximately 10% to 25% are inherited in an autosomal dominant fashion (79). The de novo occurrence of 22q deletion is observable in about 90% to 95% of affected individuals in all populations (182). Other chromosomal rearrangements, including an interstitial deletion at 10p13, are reported in individuals with the DiGeorge syndrome phenotype (37).
Cytogenetics. Approximately 76% of patients to 90% of patients with DiGeorge and velocardiofacial syndrome have a 1.5 Mb to 3 Mb microdeletion within chromosome 22q11, referred to as the "typically deleted region." The typically deleted region is subdivided into five intervals, encompassing some 50 genes (180). To date, no significant correlation exists between the size of the deletion and the severity of the phenotype (27). Furthermore, considerable variability occurs in the phenotype observed within individual families, indicating that the phenotype is not solely related to the size of the deletion (40; 115; 27). Both deletions and reciprocal duplications have been identified in patients with varying phenotypes by chromosomal microarray analysis (110). Genetic factors play a major role in the phenotypic variability of a mouse model of DiGeorge syndrome (183). Some reports have shown that the proximal or distal location of the microdeletion is related to the prevalence of associated features (34).
The following table lists some of the DiGeorge and velocardiofacial syndrome candidate genes within the typically deleted region. TBX1 is the most likely of the candidate genes and is located in the 22q11 region most often deleted (84). Mutations in TBX1 have also been identified in non-deleted patients and are thought to be causal based on functional and experimental data (173; 01). TBX is the most important gene for expression of cardiovascular phenotype. This gene regulates tissue and organ morphogenesis during embryogenesis, especially of the heart outflow tracts. It also impairs the development of neural crest-derived mesenchymal cells that surround the third pharyngeal pouch leading to thymic hypoplasia (34). Other genes remain under investigation.
Gene |
Function |
Reference |
CLTD |
Encodes a protein with homology to human clathrin heavy-chain |
(68) |
COMT |
Catechol-O-methyltransferase: a CNS enzyme involved in the metabolic degradation of dopamine and norepinephrine; increased prefrontal dopamine may affect cognition and contribute to psychosis in patients. |
(76; 70) |
CRKL |
Encodes an SH2-SH3-SH3 adaptor protein |
(77) |
CTP |
Mitochondrial citrate transport protein |
(66) |
DGCR2 or LAN or IDD |
Encodes a potential adhesion receptor protein |
(39; 205) |
DGCR6 |
Encodes a putative protein that has homology to the human laminin gamma-1 chain and Drosophila gonadal protein |
(41) |
DGCR8 |
Encodes a protein containing one WW motif and two DSRM motifs |
(163) |
DVL-22 |
A human homologue of the Drosophila disheveled segment-polarity gene |
(146) |
GNB1L |
Encodes a G-protein beta-subunit-like polypeptide |
(67) |
GSCL |
Homology to the homeodomain family of transcription factors (goosecoid-like homeobox gene) |
(71) |
HIRA |
Human homologue of the S cerevisiae HIR1 and HIR2 transcriptional repressors (essential for hematopoiesis experimentally) |
(103; 29) |
PCQAP |
Encodes a protein subunit of the multiprotein complex PC2 |
(17) |
RanBP1 |
Binding partner of the Ras-related nuclear protein Ran/TC4 |
(122) |
TBX1 |
T-box transcription factor |
(87; 173) |
TMVCF |
Encodes a transmembrane protein |
(168) |
TUPLE1 |
A putative transcription factor |
(78) |
UFD1L |
Encodes a protein involved in degradation of ubiquitinated proteins |
(218) |
ZNF74 |
A putative transcription factor |
(12) |
Central nervous system findings. The 22q11.2 region contains many genes that are critical to neuronal development and migration, so it follows that brain morphology and genetic variation at this locus are closely related (114). Neuroanatomic anomalies may be seen on CT and MRI scans in a minority of individuals with DiGeorge and velocardiofacial syndrome, and to date, they vary considerably. Findings include cerebral atrophy, hypoplasia of the cerebellar vermis, small posterior fossa, small cysts adjacent to the anterior horns, gray matter heterotopias consistent with abnormal neuronal migration, hippocampal hypoplasia, Chiari malformation, focal white matter signal hyperintensities, enlargement of the corpus callosum, and polymicrogyria (154; 05). A study of cortical architecture revealed cortical dysplasia in one affected patient; this form of arrested maturation was evident in all lobes of the cortex and probably represents the persistence of the normal radial columnar architecture of the neocortical plate in the first half of gestation (157). Quantitative volumetric neuroimaging studies show reduced tissue volumes in the nonfrontal lobar regions of the brain, consistent with the neurocognitive profile of DiGeorge and velocardiofacial syndrome (94). High-resolution imaging studies show a significant reduction in frontal deep white matter, suggesting frontostriatal dysfunction, a finding noted in individuals with schizophrenia (93). Decreased cortical gyrification in medial temporal and occipital regions is associated with increases in negative psychiatric symptomatology (127). Diffusion tensor imaging has demonstrated altered integrity of white matter in the superior and inferior longitudinal fasciculi and thalamic to frontal tracts, which may contribute to behavioral abnormalities or deficits in visual-spatial memory in patients (96; 200). It has been hypothesized that the psychiatric and cognitive deficits may be due to disordered structural and functional connectivity, as well as abnormalities in association pathways and midline structures (eg, corpus callosum, cingulate gyrus) (160). Widespread alterations in the subcortical regions of affected patients are associated with size of deletion and degree of psychosis; these changes overlap with those in patients manifesting idiopathic schizophrenia and other forms of severe psychiatric disease (30; 153).
Congenital heart disease, craniofacial malformations, endocrinopathies, and immunodeficiencies. During the fourth week of embryonic development, neural crest cells migrate into the pharyngeal arches and participate in the formation of the craniofacial region, aortic arches and conotruncus, thymus, and parathyroid glands (18). It is likely that the recognizable features in DiGeorge and velocardiofacial syndrome patients (unique facial features, congenital heart disease, thymus hypoplasia, parathyroid hypoplasia) result from either aberrant neural crest cell migration or from a disorder of cell interaction with pharyngeal pouch endoderm from which the affected structures are derived (18).
DiGeorge and velocardiofacial syndrome studies suggest a role for TBX1 in mediating epithelial-mesenchymal signaling in regions of the developing face of the mouse (224). The transcription factor encoded by TBX1 is important to cardiac development and is often deleted in patients (174). It is also required for the elongation and elevation of palatal shelves (72) and pharyngeal development (47).
Several patients have been reported with primary lymphedema, which may result from an altered influence of TBX1 on lymphangiogenesis (190).
Neurochemical or neuropsychiatric disorders. The catechol-O-methyltransferase gene is located within the region typically deleted in DiGeorge and velocardiofacial syndrome (76). The gene encodes an enzyme that inactivates catecholamines such as dopamine, norepinephrine, and epinephrine (48). Presence of catechol-O-methyltransferase (COMT) activity may serve as a functional barrier for catecholamines in the brain (89) and placenta (14). Catechol-O-methyltransferase occurs in soluble and membrane-bound forms but resides predominantly in the cytoplasm. The soluble form has high and low activity alleles. Low catechol-O-methyltransferase activity has been reported in women with primary affective disorder (32).
Individuals hemizygous for the catechol-O-methyltransferase gene (such as those with a 22q11.2 deletion) and carrying a low activity allele on their nondeleted chromosome may be predisposed to the development of psychotic features (102). This could occur either due to decreased inactivation of catecholamines in the brain, increased placental transfer of catecholamines, or both. The specific catabolic clearance of dopamine has been implicated as well (10). Approximately 23% of a randomly selected population was classified as "low" metabolizers (209); therefore, the frequency of the low activity allele in the DiGeorge and velocardiofacial syndrome population may be significant. This functional COMT polymorphism may have a gender-moderated effect on the neuroanatomic phenotype in individuals with DiGeorge and velocardiofacial syndrome (92).
Expression studies performed in mice and humans show that most 22q11.2 genes are expressed in the brain during multiple stages of development (123). Thus, the neuropsychiatric findings in individuals with DiGeorge and velocardiofacial syndrome may be the result of the deletion of multiple 22q11.2 genes. Additional experimental evidence suggests that deficits in emotional memory and in establishing proper contexts for emotions may be due to microRNA-dependent disruption of thalamic synaptic transmission to the amygdala (52).
Renal anomalies. Urologic malformations associated with 22q11.2 deletions may represent variable expression of an embryologic defect of the lower or upper ureteral bud (42). Anorectal anomalies may be related to a defect in mesenchyme cell migration, an abnormality of the cell matrix, or defect in programming (216).
DiGeorge and velocardiofacial syndrome is one of the most common multiple malformation syndromes. It is the most common microdeletion disorder in humans (01). The combined incidence of DiGeorge and velocardiofacial syndrome has been estimated to be approximately 1 in 2000 (164) to 1 in 4000 (126). Males and females are affected equally, with no apparent differences among ethnic groups (126).
The 22q11.2 deletion syndrome can occur in combination with other conditions, thus complicating diagnosis. Differential diagnosis may include autosomal dominant Opitz GBBB syndrome (vascular ring and cardiovascular defects, developmental delay, cleft palate), CHARGE association (cardiovascular defects, growth deficiency, developmental delay, cleft palate, cranial nerve abnormalities, renal anomalies), and Kabuki syndrome (cardiovascular defects, renal abnormalities, developmental delay, growth deficiency, cleft palate). VATER, Alagilee, and Goldenhar syndromes as well as isotretinoin embryopathy have clinical links with 22q deletion syndrome (35).
Care must be taken to distinguish hypocalcemic seizures from epilepsy (188); distal deletion of 22q11.2 is clinically different from more proximal deletions of 22q11.2 (117).
A prenatal screening panel that includes 22q11.2 deletion syndrome is being tested (203). Fetal DNA can be obtained in the first trimester from maternal blood and, thus, enable early diagnosis (47). The efficacy of cell-free DNA screening is under scrutiny as well (85). The finding of a conotruncal anomaly by prenatal ultrasound or other diagnostic workup should compel caretakers to search for this deletion. The condition can be encountered in undiagnosed adults as well (202).
Chromosomal microarray technology provides the most clinically useful information for diagnosis (139). Diagnosis may be overlooked for many years, as evidenced by highly diverse cases. The average diagnosis time is almost 2 years (207). The presence of epilepsy can confound the diagnosis of 22q11.2 deletion syndrome (108). In one boy, a hypocalcemic seizure occurred at 8 years of age and led to the diagnosis (167); in another, adult-onset hypoparathyroidism was diagnosed in a 71-year-old psychiatric patient (142). Similarly, the diagnosis was made in one 62-year-old woman with schizophrenia, intellectual disability, hypoparathyroidism, and macrothrombocytopenia (219). These cases speak to the need for astute workups and the risk of unnecessary treatments.
Initial laboratory evaluations in the neonatal period should include serum calcium measurements and absolute lymphocyte count determination. Low calcium warrants calcium supplementation. Calcium homeostasis typically normalizes with age, although recurrence of hypocalcemia in later childhood and adulthood has been reported (74; 181). Therefore, periodic serum calcium screening is recommended (185). A low absolute lymphocyte count necessitates evaluation of T-cell and B-cell subsets and immunology referral. Partial immunodeficiency is a cause of recurrent sinus and pulmonary infection in childhood (60). Infants with severe immunocompromise should not receive live vaccines (oral polio or measles, mumps, rubella vaccine) and should be re-evaluated before receiving a live vaccine during childhood. Likewise, patients need to receive irradiated blood products to avoid the serious complication of transfusion-associated graft-versus-host disease (133). Severe immune deficiency may require bone marrow transplantation (107). Transplantation of T cells or cultured thymus tissue has proven successful, eliminating the need for prophylactic antibiotics and immunoglobulin therapy (119; 126; 60). Infusion of HLA-matched sibling donor T lymphocytes has proven successful in combating severe adenovirus infection (86). Transplantation of thymic and parathyroid tissue is in the early stages of development (101).
Renal ultrasound is recommended due to the increased incidence (approximately 30%) of structural renal abnormalities in these individuals that are not readily detectable by other means (42).
An endocrine workup is indicated. Children with short stature should be evaluated for growth hormone deficiency as they may be at increased risk for pituitary abnormalities (210). Abnormal pituitary development also confers increased susceptibility to atypical neurodevelopment and psychopathology (156). Reduced growth may also result from genetic factors or cardiovascular deficiency (121). Growth tends to be restricted at all ages, and at adulthood, patient height will probably be in the low-normal range (113). In addition, hypoparathyroidism and hypocalcemia can lead to reduced mineralization of bone and can require monitoring of bone metabolism and bone mineral density (57).
Early educational intervention is suggested. Speech and language assessment may aid in diagnosing a congenital or iatrogenic (for example, paralyzed vocal cord) airway abnormality, with subsequent referral to an appropriate specialist for management (50). Cephalometry (ie, measurement of cranial base angle, nasopharyngeal depth, velum and velopharyngeal length, and other dimensions) may help assess the severity of velopharyngeal dysfunction (196). Candidates for pharyngeal flap correction of velopharyngeal insufficiency should have an MRA to identify ectopic internal carotid arteries that may pose a risk for surgery (138). In one study, pharyngoplasty proved more efficacious than palatoplasty alone, which may require additional surgery (170). Velopharyngoplasty results in normal voice resonance in about one-half of patients, although this may take up to 5 years to develop following surgery; the remainder may manifest residual hypernasality or require further surgery (171). Superiorly based pharyngeal flap surgery has led to improvement in hypernasality, audible nasal emission, and speech intelligibility in a group of 12 patients (58). Combined palatoplasty and sphincter pharyngoplasty have proven effective as well (19). Poor sleep quality may result from elevated inflammatory markers recognized in the syndrome and may contribute to gastrointestinal symptoms (eg, nausea, diarrhea, abdominal pain, constipation) and cognitive impairment (105; 220). Sleep difficulties appear to be lessened with improved bedtime routine and sleep environment, rather than medication (08). Formal neuropsychological testing is strongly recommended for all children (139).
The use of methylphenidate for ADHD in this population is routinely avoided due to concerns about psychotic exacerbation. However, an open-label study notes that methylphenidate is both a safe and effective treatment for ADHD in children with DiGeorge and velocardiofacial syndrome (69). S-adenosyl-L-:methionine (SAMe) is thought to enhance the COMT enzyme and has proven to be effective in the treatment of patients with depression with or without psychotic symptoms, though no improvement in ADHD symptoms was apparent (73).
The risk of psychiatric illness is present at birth, of course, and early diagnosis and treatment may lead to improved outcomes. Longitudinal studies have identified certain childhood predictors of adult socialization, especially child internalizing symptoms and adolescent problem behavior (206). These are conditions that warrant early intervention. Unfortunately, it is not clear that young patients with psychiatric disorders at the milder end of the spectrum (ie, nonpsychotic) receive the help they need. In one Italian study, only 27% of children and teens received psychiatric treatment (09). Genetic counselors play an integral but also challenging role in this (120) and should realize that parents use the internet for their main source of information about the syndrome (194).
Dysfunction in fast intracortical oscillatory processing, identified by EEG, may serve as a risk marker for schizophrenia in some patients (104). Treatment of the psychiatric illness of patients with DiGeorge and velocardiofacial syndrome is challenging, and patients may show varied response to neuroleptic therapy (135; 04).
Practice guidelines for managing pediatric patients were first published in 2011 (139) and for adult patients in 2015 (23). It is important to know that adults with 22q11.2 deletion syndrome require follow-up, regardless of age of diagnosis (23).
Prenatal diagnosis is available utilizing fluorescence in-situ hybridization analysis on amniocytes, chorionic villi, or fetal lymphocytes (percutaneous umbilical cord sampling). Although definitive, such testing is invasive, and noninvasive screening of cell-free DNA in maternal serum is becoming more common (75; 208). Referral to a perinatal genetics center is suggested so that parents receive appropriate genetic counseling. Polyhydramnios in affected patients may signal airway obstruction (155). As affected individuals become able to reproduce, the prevalence of the disorder is likely to rise; at present, an estimated 6% to 10% of cases are familial (126).
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Robin Godshalk MS MHA
Dr. Godshalk of Fragile X Center at Atlantic Health System in Morristown, New Jersey has no relevant financial relationships to disclose.
See ProfileGaneshwaran H Mochida MD
Dr. Mochida of Boston Children's Hospital and Harvard Medical School has no relevant financial relationships to disclose.
See ProfileNearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Epilepsy & Seizures
Sep. 06, 2024
Developmental Malformations
Aug. 11, 2024
Developmental Malformations
Aug. 06, 2024
Developmental Malformations
Jul. 04, 2024
Developmental Malformations
Jul. 02, 2024
Developmental Malformations
Jun. 28, 2024
Developmental Malformations
Jun. 23, 2024
Neurobehavioral & Cognitive Disorders
Jun. 05, 2024